Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis - sprookjes - yvandenbroek - TriplyDB

Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis

Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis

http://www.wikidata.org/entity/Q35842980

about

Physical biology in cancer. 4. Physical cues guide tumor cell adhesion and migration Receptor tyrosine kinase-mediated angiogenesis Mouse models for studying angiogenesis and lymphangiogenesis in cancer Progression and metastasis of lung cancer Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems Orchestration of angiogenesis by immune cells Anti-cancer activity of an osthole derivative, NBM-T-BMX-OS01: targeting vascular endothelial growth factor receptor signaling and angiogenesis Tumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophages Tie1 controls angiopoietin function in vascular remodeling and inflammation.Lymphovascular and neural regulation of metastasis: shared tumour signalling pathways and novel therapeutic approaches.Direct endothelial junction restoration results in significant tumor vascular normalization and metastasis inhibition in mice Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions.Omega-3 polyunsaturated fatty acids enhance cerebral angiogenesis and provide long-term protection after stroke.The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer Primary and secondary lymphatic valve development: molecular, functional and mechanical insights.Expression of angiopoietin-2 and vascular endothelial growth factor receptor-3 correlates with lymphangiogenesis and angiogenesis and affects survival of oral squamous cell carcinoma.Endothelial destabilization by angiopoietin-2 via integrin β1 activation.Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1 Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2.Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma.Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.Synergistic actions of blocking angiopoietin-2 and tumor necrosis factor-α in suppressing remodeling of blood vessels and lymphatics in airway inflammation Molecular regulation of lymphangiogenesis in development and tumor microenvironment.Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited.Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis Revascularization of the graft in obliterative bronchiolitis after heterotopic tracheal transplantation.Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages.Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression Activation of hypoxia response in endothelial cells contributes to ischemic cardioprotection.Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.MiR-145 functions as a tumor suppressor via regulating angiopoietin-2 in pancreatic cancer cells.Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation.Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche.Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases.Heterogeneous perivascular cell coverage affects breast cancer metastasis and response to chemotherapy Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy

P2860

Q26863598-2927A9E8-6161-45A7-BFF3-AB5546985F74 Q27001612-AE04DE6B-34A0-491E-8540-7B1BC14E5712 Q27003898-85EFED29-1780-4572-9D00-A255E43C9020 Q28066865-6751B41D-B8D5-4120-BEB6-8EBFD6D0858C Q28070234-1EDC2212-EE8C-41EF-82D3-87CF1C0A274A Q28389236-150E24EF-391A-4A29-AD72-192D77F8954A Q28535457-C2E6F1B8-4A11-4EFC-B9E7-FE8798A16844 Q28539655-C050AE64-E15D-4BAC-80A1-9D8BACB19C9F Q30805233-0766D3D8-1018-4B98-8350-2EBF37B99C2E Q33555154-AD6EEB97-8BC2-4CF9-8ADE-068B87C26804 Q33757106-C7F2F1F7-2D2F-401A-AD5B-0D90CF96F23C Q33867596-D6DED02F-A64A-452F-B35A-B7F9D5F15DC9 Q33917453-B5973218-8AB3-48D6-9F64-C48BA6053DB6 Q34002094-2499253B-1A42-409D-805C-9B81D7167D28 Q34056427-61F5A32D-3753-4CA1-810B-7A0124D13504 Q34432002-EE237E12-D6F6-49A3-8E25-C4BDFA71F3A7 Q34990607-E607AA75-682C-470D-ADEA-823D52554521 Q35047913-BD62B3EA-FF15-4F9C-899F-8BFBB6BE1D5B Q35126158-1A5F7D19-0B0A-430B-A9EB-1B42B774F5B4 Q35238403-724C1A3A-F90F-4D4F-A1D8-4ADA6D58702D Q35695381-F74F0371-7965-48D7-B281-412E98622A0F Q35995721-75D87681-21D1-4E94-8825-1F364C88B762 Q35995921-FC3D3C3D-547A-4E72-A893-B8373890D93E Q36240638-90102DFB-D9CA-4493-ACE7-EA585727363F Q36284953-A431F7A6-B438-4518-8B98-A972E6FE80C5 Q36428702-56E0B648-42F6-403D-BBAF-4682CA6B56D1 Q36477818-A1018287-819D-4469-B76B-58DECE9F88EB Q36534347-F161FCAE-FA1E-46ED-A919-8E6FB8C868F8 Q36754289-72A56D43-EE72-4FE8-BC6B-8228C974C544 Q36831553-7CE3D5C9-6A69-4FCB-B591-87B0F9D9DAEE Q36994123-17143031-E043-478A-A9E9-47B90987CBBE Q37106787-21E1EE69-BB14-4FC6-921E-3467C797D439 Q37122871-36BCE806-BCAE-4843-825A-3CB78F4D31FD Q37174690-A1CD89D7-5B3F-49B7-A29F-5DC86F5CFD42 Q37209635-BFB4350E-87EC-43A0-8FA5-0F12D65F4A3E Q37239068-6638C654-E7DA-40B9-A050-E0736D87DCEA Q37340509-1BD261A8-D712-44EC-9D7F-21899DB8E095 Q37507440-70EF0937-FFAB-44E9-BD41-ED6E3E788F3E Q37509823-43E66CBC-70C0-4028-A69C-60EF04F7F2FE Q37524215-F60F3B71-1E3F-4E0D-A3EF-C2C1AEA7BB80

P2860

Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis

http://www.wikidata.org/entity/Q35842980

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Effects of angiopoietin-2-bloc ...... junctions and lung metastasis

@ast

Effects of angiopoietin-2-bloc ...... junctions and lung metastasis

@en

type

label

Effects of angiopoietin-2-bloc ...... junctions and lung metastasis

@ast

Effects of angiopoietin-2-bloc ...... junctions and lung metastasis

@en

prefLabel

Effects of angiopoietin-2-bloc ...... junctions and lung metastasis

@ast

Effects of angiopoietin-2-bloc ...... junctions and lung metastasis

@en

P1433

Q35842980-D579D1B4-9454-4AE6-BB6D-DA7E5932BB67

P1476

Q35842980-1C468004-8CE0-4542-AD3F-EDDD8D56A804

P2093

Q35842980-1E4129B9-E637-4E98-8156-D41A8A4C7C17

Q35842980-2168C23A-4FC3-4A84-8671-0B3AFA0053CD

Q35842980-2C42794F-6461-4537-BA65-0D4E836F2308

Q35842980-38C27734-1F9E-4BBB-AAC8-1F49A38FBCF0

Q35842980-4C21AC2C-BEAF-4ED7-9FA1-7DFB08C8AF9D

Q35842980-8BB71692-8420-4F62-A9E4-9893FDFFBB83

Q35842980-9867AC69-273E-47D6-A4F4-AEE6C519C99B

Q35842980-A85E3801-E71C-4F42-881F-BE63A080AD09

Q35842980-AA8AE616-5C2A-4F06-8862-83B622AD25F5

Q35842980-AA99C2FD-42A2-4593-81D3-44C3762CEF7B

P2860

Q35842980-03DF4B29-F22B-48AE-B341-169C4C253216

Q35842980-08AD2246-313F-4FE8-864C-79914BDD306B

Q35842980-0BAC155F-2CCD-4E41-966B-E0F31C2A26A1

Q35842980-0EE540CD-272A-4494-99F3-B938311B4228

Q35842980-10A9FBA3-58C2-4BB3-BA99-C29D2A57D623

Q35842980-129242B3-1CBC-4D26-A8B3-E9E482935B93

Q35842980-17AF3399-A081-46D9-907B-64320621C0EE

Q35842980-187B8044-C3D7-4241-AEE3-9DA7D903556A

Q35842980-1B84CD34-55EF-4B1C-A7B1-F16887AAC18E

Q35842980-1CB0CC79-17AB-412D-BF5D-B09A8C3283DC

P304

Q35842980-EFEE24BB-6E25-43B5-AD5D-73300D4B8EB8

P31

Q35842980-7CFC343A-3E4C-4EC4-8037-0629E02952A7

P356

Q35842980-0D47594B-52D1-4A1C-811A-E3FAC6FA527D

P407

Q35842980-F9CFA6BA-2A98-4797-B3C0-31CABD0C84E3

P433

Q35842980-52782134-A934-46E7-8936-C0B940FD6362

P478

Q35842980-F1251ADD-E49E-4C7C-8E8A-8E629AF2405D

P50

Q35842980-421FD949-E12D-4C81-BEA2-03BEC2F31FA3

Q35842980-D9D88F9A-26D0-4BAC-985A-5E3AB9B78046

Q35842980-E6A53695-EAFF-4A97-AEC0-21BDB045A49E

Q35842980-EDEEAE1C-ED3B-47B2-B99C-1B6A7C7A7D2C

P577

Q35842980-7CC9E5EB-001E-4762-9A7C-AF1E47FAB686

P5875

Q35842980-9C4C6159-947F-4F24-B245-A11F9EC629A8

P698

Q35842980-5760B551-B0E6-4702-A0D7-16D0B4934D9F

P921

Q35842980-8B623962-41F4-4502-98BF-A2991436BD4F

Q35842980-C0EA98FB-8DDB-4669-86EA-F58CECB620D7

P932

Q35842980-603CF2F6-27CC-4FA3-8505-721C893111C6

P356

P1433

Journal of the National Cancer Institute

P1476

Effects of angiopoietin-2-bloc ...... junctions and lung metastasis

@en

P2093

Andrey Anisimov

http://www.w3.org/2001/XMLSchema#string

Anita Lampinen

http://www.w3.org/2001/XMLSchema#string

Ching Ching Leow

http://www.w3.org/2001/XMLSchema#string

Gabriela D'Amico

http://www.w3.org/2001/XMLSchema#string

Georgia Zarkada

http://www.w3.org/2001/XMLSchema#string

Gou Young Koh

http://www.w3.org/2001/XMLSchema#string

Hanna Heloterä

http://www.w3.org/2001/XMLSchema#string

Laura E Benjamin

http://www.w3.org/2001/XMLSchema#string

Lauri Eklund

http://www.w3.org/2001/XMLSchema#string

Marja Lohela

http://www.w3.org/2001/XMLSchema#string

P2860

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning

Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium

Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis

Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation

Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts

Differential function of Tie2 at cell-cell contacts and cell-substratum contacts regulated by angiopoietin-1

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels

P304

461-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJS009

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Seppo Ylä-Herttuala

Pipsa Saharinen

P577

2012-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221840595

http://www.w3.org/2001/XMLSchema#string

P698

22343031

http://www.w3.org/2001/XMLSchema#string

P921

P932

3309130

http://www.w3.org/2001/XMLSchema#string